MXCT
MaxCyte Inc
NASDAQ: MXCT · HEALTHCARE · MEDICAL DEVICES
$0.84
-3.24% today
Updated 2026-05-08
Market cap
$90.34M
P/E ratio
—
P/S ratio
2.74x
EPS (TTM)
$-0.42
Dividend yield
—
52W range
$1 – $2
Volume
0.9M
MaxCyte Inc (MXCT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.13M | $-557800.00 | $-1.93M | $-180500.00 | $-2.33M | $-9.68M | $-10.49M | $-8.80M | $-8.78M | $-10.68M | $-14.78M | $-21.69M | $-27.61M | $-34.41M |
| Capital expenditures | $17400.00 | $49500.00 | $147000.00 | $94500.00 | $218800.00 | $609700.00 | $709700.00 | $1.27M | $2.07M | $3.83M | $18.48M | $3.70M | $1.65M | $1.77M |
| Depreciation | $115200.00 | $116400.00 | $92000.00 | $93300.00 | $105700.00 | $142900.00 | $344000.00 | $613500.00 | $1.05M | $1.42M | $2.70M | $4.57M | $4.32M | — |
| Stock-based comp | $36700.00 | $5700.00 | $95600.00 | $1200.00 | $154100.00 | $514500.00 | $1.32M | $1.75M | $2.47M | $7.96M | $11.75M | $13.98M | $13.08M | $9.21M |
| Free cash flow | $-2.14M | $-607300.00 | $-2.07M | $-275000.00 | $-2.55M | $-10.29M | $-11.20M | $-10.07M | $-10.85M | $-14.51M | $-33.26M | $-25.39M | $-29.26M | $-36.18M |
| Investing cash flow | $-11500.00 | $-49500.00 | $-147000.00 | $-94500.00 | $-218800.00 | $-609700.00 | $-3.83M | $454500.00 | $-16.58M | $-195.01M | $-24.82M | $54.98M | $6.93M | — |
| Financing cash flow | $1.37M | $-46300.00 | $4.72M | $-722100.00 | $11.87M | $23.90M | $226800.00 | $12.31M | $28.90M | $234.72M | $2.89M | $2.14M | $2.06M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | $29.03M | $-36.72M | — | — | — |